ADMA Biologics
Mr. Gruenglas is Senior Director, Government Affairs and Health Policy, for ADMA Biologics. In this capacity, he plays a central role in developing and implementing coordinated advocacy strategies and engagements with governmental and policy entities around issues that impact the IVIG therapeutic area and biopharmaceuticals in general.
This person is not in any offices
ADMA Biologics
3 followers
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.